<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Life</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Med Life</journal-id>
      <journal-id journal-id-type="publisher-id">JMedLife</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medicine and Life</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1844-122X</issn>
      <issn pub-type="epub">1844-3117</issn>
      <publisher>
        <publisher-name>Carol Davila University Press</publisher-name>
        <publisher-loc>Romania</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24653762</article-id>
      <article-id pub-id-type="pmc">3956101</article-id>
      <article-id pub-id-type="publisher-id">JMedLife-07-75</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Presentation</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Non-steroidal anti-inflammatory drug &#x2013; induced transient reactive papulotranslucent acrokeratoderma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Orzan</surname>
            <given-names>OA</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
          <xref ref-type="aff" rid="A2">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Popa</surname>
            <given-names>LG</given-names>
          </name>
          <xref ref-type="aff" rid="A2">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Voiculescu</surname>
            <given-names>V</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Manta</surname>
            <given-names>R</given-names>
          </name>
          <xref ref-type="aff" rid="A2">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Giurc&#x103;neanu</surname>
            <given-names>C</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
          <xref ref-type="aff" rid="A2">**</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>*</label>"Carol Davila" University of Medicine and Pharmacy, Bucharest</aff>
      <aff id="A2"><label>**</label>"Elias" Emergency Hospital, Department of Dermatology</aff>
      <author-notes>
        <corresp><bold>Correspondence to:</bold>Orzan Olguta Anca, MD
"Elias" Emergency Hospital, Department of Dermatology, 17 Marasti Blvd., 011461, Bucharest, Romania
Phone: +4021 316 1600
</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <volume>7</volume>
      <issue>1</issue>
      <fpage>75</fpage>
      <lpage>77</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>9</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;Carol Davila University Press
</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is 
an open-access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work 
is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Transient reactive papulotranslucent acrokeratoderma (TRPA) is an unusual skin condition characterized by the rapid and transient development of symmetric, edematous white papules with eccrine duct prominence on the palms after exposure to water. We present the case of a 28-year-old woman diagnosed in our clinic with TRPA induced by the use of a non-steroidal anti-inflammatory drug. The possible pathophysiology and treatment options are discussed.</p>
      </abstract>
      <kwd-group>
        <kwd>non-steroidal</kwd>
        <kwd>papulotranslucent acrokeratoderma</kwd>
        <kwd>palmar wrinkling</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-1">
      <title>Introduction</title>
      <p>Transient reactive papulotranslucent acrokeratoderma (TRPA), also known as acquired aquagenic palmoplantar keratoderma, aquagenic keratoderma, aquagenic wrinkling of the palms, and aquagenic syringeal acrokeratoderma [<bold><xref rid="R1" ref-type="bibr">1</xref></bold>] is an unusual skin condition characterized by the rapid and transient development of symmetric, edematous white papules with eccrine duct prominence on the palms after exposure to water. It is a rare disorder, fewer than 40 cases having been reported in literature. It mainly affects young women, reported patients being aged between 6 and 50 years. </p>
      <p> The majority of reported cases of TRPA have associated cystic fibrosis, the &#x3B4;F508 CFTR (cystic fibrosis transmembrane conductance regulator) mutation being thought to be a predisposing factor for this disease [<bold><xref rid="R2" ref-type="bibr">2</xref></bold>]. A cystic fibrosis carrier state, a cutaneous barrier function defect, hyperhidrosis and the intake of cyclooxygenase inhibitors may also be pathogenic factors.
</p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>We present the case of a 28-year-old woman who was evaluated in our clinic for a several-weeks history of exaggerated palmar wrinkling and swelling after 3-4 minutes exposure of her hands to water. She reported having experienced the same signs and symptoms the previous year for approximately 3 weeks, but the abnormalities healed spontaneously after this interval with diffuse descuamation of the palmar surfaces.</p>
      <fig id="F1" position="float">
        <label>Fig. 1</label>
        <caption>
          <p>Exaggerated palmar wrinkling</p>
        </caption>
        <graphic xlink:href="JMedLife-07-75-g001"/>
      </fig>
      <p>Physical examination revealed normal skin on her palms. The rest of the general physical examination did not reveal pathologic changes. Following brief exposure to water at room temperature (4 minutes), she developed swelling and a whitish discoloration of the palms, followed by the appearance of 1-2 mm white, translucent papules, coalescing into pebbly plaques distributed diffusely on the palmar surfaces, consistent with a positive &#x201C;hand in bucket" sign. In addition, the eccrine pores were more prominent. The patient complained of local disconfort during the episode. After drying, the signs and symptoms resolved spontaneously within thirty minutes. </p>
      <p> The patient did not associate palmoplantar hyperhidrosis. She was not aware of any family history of TRPA or cystic fibrosis and tested negative for &#x3B4;F508 CFTR mutation. She refused skin biopsy. </p>
      <p> The patient denied any concomitant medication except for Ketorolac, a non-steroidal anti-inflammatory drug, which she occasionally administered for low back pain during the previous month. When asked, the patient admitted to have taken Ketorolac for the same condition the previous year and correlated the appearance of the described cutaneous signs with the initiation of the anti-inflammatory treatment.</p>
      <p> Treatment with Ketorolac was stopped. The patient was advised to avoid water exposure as much as possible and to wear gloves. She was recommended 9% aluminum chloride cream and a barrier hand cream that resulted in a slight improvement of the symptoms. One week following the discontinuation of the anti-inflammatory therapy, the patient presented diffuse desquamation of the palms. Afterwards, the aquagenic palmar lesions ceased to appear. </p>
    </sec>
    <sec sec-type="Discussion" id="sec1-3">
      <title>Discussion</title>
      <p> Two types of papulotranslucent acrokeratoderma have been described in literature, hereditary and transient reactive. </p>
      <p> Onwukwe et al. were the first to describe the condition in 1973, as hereditary papulotranslucent acrokeratoderma (HPA), an autosomal dominant disease presenting with persistent asymptomatic bilateral, translucent, yellowish-white papules and plaques located especially on areas of increased pressure and trauma on the palms and soles. Similar cases were later reported by Koster and Nasemann in 1985 and Heymann in 1998 [<bold><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></bold>]. An association with atopy and fine-textured scalp hair was observed in these cases. The pathogenesis of HPA is unknown. As only palms and soles are affected, it was hypothesized that physical trauma is an initiating factor [<bold><xref rid="R5" ref-type="bibr">5</xref></bold>]. Specific treatments for HPA are not usually necessary because the condition is generally asymptomatic [<bold><xref rid="R6" ref-type="bibr">6</xref></bold>]. </p>
      <p> In 1996, English and McCollough reported the first cases of transient reactive papulotranslucent acrokeratoderma. They described two sisters with episodic development of white papules and plaques on the palms that became edematous and painful following exposure to water [<bold><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>-<xref rid="R12" ref-type="bibr">12</xref></bold>]. Since then, a few other cases with the aquired form of disease have been described [<bold><xref rid="R7" ref-type="bibr">7</xref></bold>]. In contrast to the hereditary form, these patients presented with transient lesions that were not limited to pressure areas of the palms and had no history of atopy. </p>
      <p> The etiopathogenesis of TRPA is still unclear. An association with cystic fibrosis and the carrier state of the cystic fibrosis gene has been suggested [<bold><xref rid="R13" ref-type="bibr">13</xref></bold>]. The clinical manifestations may be caused by an increased epidermal sodium level, leading to increased water retention within keratinocytes. Abnormal regulation by CFTR of cell-membrane water channels, such as aquaporin 3, defective stratum corneum barrier function, occlusion of the eccrine duct ostia, or weakness of the eccrine duct wall have also been incriminated [<bold><xref rid="R2" ref-type="bibr">2</xref></bold>]. Moreover, TRPA secondary to the use of non-steroidal anti-inflammatory drugs (aspirin [<bold><xref rid="R14" ref-type="bibr">14</xref></bold>] and rofecoxib [<bold><xref rid="R15" ref-type="bibr">15</xref></bold>]) has been described. Cyclooxygenase-2 (COX-2) inhibitors increase sodium reabsorption in the kidney by their effects on renal vasculature. COX-2 is also present in keratinocytes and its inhibition may cause increased sodium reabsorption and, subsequently, increased keratin water-binding capacity [<bold><xref rid="R14" ref-type="bibr">14</xref></bold>].</p>
      <p> Clinically, TRPA is characterized by the appearance of white or translucent papules that coalesce into pebbly plaques on the palmar surfaces following short exposure to water. Soles are usually unaffected. The changes may be asymptomatic or accompanied by local discomfort, pruritus, a burning sensation or even pain. In most cases, the palmar skin returns to normal within a few minutes after drying. Sometimes, patients also suffer from palmoplantar hyperhidrosis. </p>
      <p> The diagnosis of TRPA is usually made on the clinical history and physical findings. The most common histologic findings are hyperkeratosis and dilated eccrine ostia [<bold><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R9" ref-type="bibr">9</xref></bold>].</p>
      <p> TRPA treatment is generally disappointing. Treatment options include providing a water barrier to prevent exposure and aluminum chloride products. Use of barrier creams such as hydrophilic petrolatum, glycerin emollients, 5-20% salicylic acid, 10% urea, and 12% ammonium lactate creams has not been shown to be effective [9,10]. Patients with associated palmar hyperhidrosis benefit from aluminum chloride-containing products [<bold><xref rid="R6" ref-type="bibr">6</xref></bold>].</p>
    </sec>
    <sec sec-type="Conclusions" id="sec1-4">
      <title>Conclusions</title>
      <p>The patient presented demonstrates a new case of TRPA. The clinical manifestations are transient and the reactivity to water is a prominent feature of the aquired form of the disease [<bold><xref rid="R9" ref-type="bibr">9</xref></bold>]. None of the patient&#x2019;s relatives present similar symptoms, nor a history of atopy. </p>
      <p> The most probable cause of TRPA in our patient was the use of non-steroidal anti-inflammatory drugs. This hypotesis is sustained by the temporal correlation between the onset of the cutaneous abnormalities and the initiation of the anti-inflammatory treatment, as well as by the complete clinical remission upon discontinuation of this treatment. </p>
      <p> Cystic fibrosis or the carrier state of cystic fibrosis gene should be considered in patients with TRPA, and patients with cystic fibrosis should be asked about symptoms of this condition. Patient interview should also focus on the use of non-steroidal anti-inflammatory drugs, as discontinuing this type of medication could lead to clinical improvement. </p>
      <p> Further observations are needed in order to elucidate the etiopathogenesis of this condition and to develop more efficient treatment modalities.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="compiler">
            <name>
              <surname>Rapini </surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Bolognia </surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <source>Dermatology</source>
          <year>2007</year>
          <publisher-loc>St. Louis</publisher-loc>
          <publisher-name>Mosby</publisher-name>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz </surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Yan </surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Aquagenic wrinkling of the palms in patients with cystic fibrosis homozygous for the delta F508 CFTR mutation</article-title>
          <source>Arch Dermatol</source>
          <year>2005</year>
          <volume>141</volume>
          <fpage>621</fpage>
          <lpage>624</lpage>
          <pub-id pub-id-type="pmid">15897385</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koster </surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Nasemann </surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Hereditary papulotranslucent acrokeratoderma</article-title>
          <source>Z Hautkr</source>
          <year>1985</year>
          <volume>60</volume>
          <fpage>211</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">3157274</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heymann </surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Hereditary papulotranslucent acrokeratoderma</article-title>
          <source>Cutis</source>
          <year>1998</year>
          <volume>61</volume>
          <fpage>29</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">9466078</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Onwukwe </surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Mihm </surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Hereditary papulotranslucent acrokeratoderma: a new variant of familial punctate keratoderma?</article-title>
          <source>Arch Dermatol</source>
          <year>1973</year>
          <volume>108</volume>
          <fpage>108</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">4716729</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan </surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Aasi </surname>
              <given-names>SZ</given-names>
            </name>
          </person-group>
          <article-title>Aquagenic palmoplantar keratoderma</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2001</year>
          <volume>44</volume>
          <fpage>696</fpage>
          <lpage>699</lpage>
          <pub-id pub-id-type="pmid">11260552</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>English </surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>McCollough </surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Transient reactive papulotranslucent acrokeratoderma</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1996</year>
          <volume>34</volume>
          <fpage>686</fpage>
          <lpage>687</lpage>
          <pub-id pub-id-type="pmid">8601664</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>8. Lowes </surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Khaira </surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Transient reactive papulotranslucent acrokeratoderma associated with cystic fibrosis</article-title>
          <source>Australas J Dermatol</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>172</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="pmid">10954989</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacCormack </surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Wiss </surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Aquagenic syringeal acrokeratoderma: Report of two teenage cases</article-title>
          <source>J Am Acad Dermato</source>
          <year>2001</year>
          <volume>45</volume>
          <fpage>124</fpage>
          <lpage>126</lpage>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Itin </surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Lautenschlager </surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Aquagenic syringeal acrokeratoderma (transient reactive papulotranslucent acrokeratoderma)</article-title>
          <source>Dermatology</source>
          <year>2002</year>
          <volume>204</volume>
          <fpage>1</fpage>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmults </surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sidhu </surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Aquagenic syringeal acrokeratoderma</article-title>
          <source>Dermatology Online Journal</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>27</fpage>
          <pub-id pub-id-type="pmid">14594600</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Betlloch </surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Vergara </surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Aquagenic keratoderma</article-title>
          <source>J Euro Acad Dermatol Venereol</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>306</fpage>
          <lpage>307</lpage>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gar&#xE7;on-Michel </surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Roguedas-Contios </surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Frequency of aquagenic palmoplantar keratoderma in cystic fibrosis: a new sign of cystic fibrosis?</article-title>
          <source>Br J Dermatol</source>
          <year>2010</year>
          <volume>163</volume>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khuu </surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Duncan </surname>
              <given-names>KO</given-names>
            </name>
          </person-group>
          <article-title>Unilateral aquagenic wrinkling of the palms associated with aspirin intake</article-title>
          <source>Arch Dermatol</source>
          <year>2006</year>
          <volume>142</volume>
          <fpage>1661</fpage>
          <lpage>1662</lpage>
          <pub-id pub-id-type="pmid">17179009</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carder </surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Weston </surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Rofecoxib-induced instant aquagenic wrinkling of the palms</article-title>
          <source>Pediatr Dermatol</source>
          <year>2002</year>
          <volume>19</volume>
          <fpage>353</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="pmid">12220285</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
